Niyogin Fintech's record carries a clean audit history, seven straight years of unqualified opinions, but the underlying picture is more complicated. The company is dismantling its subsidiary stack, has swung from zero debt to ₹124.5 crore of borrowings in two years, and has posted negative operating cash flow in every reported year. Its reported profits lean on accounting choices, and its governance record shows repeated insider-trading violations and auditor churn.
Key findings
- Niyogin is selling one material subsidiary to its own director and diluting another below 50%
Major- On August 13, 2026, the Board approved selling a 58% stake and all CCPs in material subsidiary Investdirect to Mr. Mohit Gang, a director of Investdirect, for up to ₹11.75 crore. On April 27, 2026, Niyogin sought shareholder approval to cut its stake in material subsidiary iServeU to as low as 10%. The company's AOC-2 disclosures state "Not Applicable" for related party transactions, even as it discloses this sale as one. - The "debt-free" narrative ended in FY24; borrowings now stand at ₹124.5 crore
Major- Niyogin reported a nil Debt:Equity ratio for four straight years through FY2023, then saw it rise to 0.35 by March 31, 2026. Borrowings closed at ₹124.5 crore in FY26, including ₹45 crore of secured NCDs, and ₹15.02 crore of fixed deposits sit under lien against overdraft lines. CRISIL assigned a 'BBB-/Negative' rating in June 2025, later revised to 'Stable' in June 2026. - Operating cash flow negative every year; no dividend recommended in four years
Major- Consolidated CFO was negative in each of the last five years, at negative ₹80.95 crore in FY26. The CFO/PAT ratio hit -218.78x in FY26, and ROCE was 4.83%. No dividend was recommended for FY2025, FY2024, FY2023, or FY2020, each due to losses. - Reported profits lean on accounting choices while consolidated PAT stays negative
Major- The company recognises no deferred tax asset on ₹43.58 crore of carried-forward tax losses, and consolidated statements also skip assets on losses at two subsidiaries. ESOP exercise prices were cut 28% during FY24, and an ECL management overlay of ₹2.56 crore was retained in FY25. Consolidated PAT was negative ₹3 crore against standalone PAT of ₹5 crore in the latest period. - Seven years of clean audit opinions stand against a growing ECL provision and Stage 3 assets
Major- The auditor issued unqualified opinions on both standalone and consolidated statements every year from FY2020 through FY2026. The ECL provision reached ₹11.21 crore and Stage 3 assets ₹24.27 crore as at March 31, 2026. Two subsidiaries with ₹245.52 crore in assets were never audited by the principal auditor. - Insider-trading violations, a 28% ESOP repricing, and a board cycling through independent directors
Major- Two designated persons sold shares without pre-clearance in 2023, drawing ₹50,000 penalties each, with payment still awaited. The MD & CEO's 8,59,854 options were cancelled and re-issued at a 28% lower exercise price. Three independent directors left between September 2024 and January 2025, while promoter-group votes at two shareholder meetings were 100% in favour. - Three statutory auditor changes in five years, with fees up 46% under the current firm
Major- BSR & Co. resigned in July 2020 over fees, and MSKA & Associates resigned in August 2021. Pijush Gupta & Co. was appointed in September 2021, and its FY2027 proposed fee of ₹26,35,380 is 46% higher than the FY2022 fee of ₹18,00,000. The signing partner has rotated between two individuals across the last three audit reports.
What to watch
- Investdirect divestment completion. Expected by March 31, 2027, subject to shareholder and regulatory approvals.
- iServeU dilution vote. Shareholder vote on the special resolution to cut the stake to up to 10%, per the April 27, 2026 postal ballot notice.
- Composite scheme approvals. NCLT Chennai Bench and other approvals pending as of the FY2025-26 Annual Report.
- Auditor re-appointment. Vote on a second five-year term for Pijush Gupta & Co. at the 38th AGM, notice dated August 27, 2026.
- CRISIL rating action. Next rating on the ₹50 crore bank facilities and NCDs, following the June 15, 2026 outlook revision to Stable.
Bottom line: This is a company with a clean audit opinion history but a cash-flow record that does not match its reported profits. The risk sits in the restructuring: the sale of a material subsidiary to a director, the planned dilution of another, and a composite scheme that will reshape the group. Watch the shareholder votes and regulatory approvals that will decide how these transactions conclude.